Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Phys Vivasrheumatological

Phys Vivas · rheumatological

Eosinophilic Disorders — Viva Defence

DCE viva defence for Eosinophilic Disorders.

On this page & tools

Target exams

FRACP DCEMRCP PACES

Target exams

FRACP DCEMRCP PACES
Prompt
DCE viva defence for Eosinophilic Disorders.

Eosinophilic Disorders Viva

Long Case Viva Defence

Opening statement

"This patient presents with a problem best framed as Eosinophilic Disorders. My priorities are to identify red flags, confirm the mechanism with purposeful investigations, start a sequenced management plan, and integrate multimorbidity and follow-up." [1] [2]

Examiner questions

Q1: "What makes this urgent?" [1]

"I look for threats to airway, perfusion, neurology, metabolism, infection or bleeding, and I escalate those before elective work-up." [1] [2]

Q2: "What is your first investigation package?" [2]

"I order tests that change management now, not a scattergun panel." [1] [2]

Q3: "Walk me through treatment." [1]

"Stabilise, treat the mechanism, prevent complications, and plan monitoring." [1] [2] [3]

Q4: "What is the classic trap?" [2]

"Treating a label without confirming the discriminating mechanism, or delaying escalation." [1] [2]

Short case

Counsel the patient on the plan, risks and warning symptoms in plain language. [1] [2]

References

  1. [1]Sanap SS, Gupta KR, Kabra UD, Umekar MJ Precision medicine in asthma: endotype stratification, biomarker-guided biologics, and emerging therapeutic strategies Mol Biol Rep, 2026.PMID 42467299
  2. [2]Utami FA, Huang SY, Liu YH, Hsu JW, et al. Aspartame and asthma: immunomodulatory effects on airway inflammation Respir Res, 2026.PMID 42464261
  3. [3]Al-Rusan O, Shen Q, Medeiros LJ From the archives of MD Anderson Cancer Center: Crystal-storing histiocytosis associated with B-cell lymphoma Ann Diagn Pathol, 2026.PMID 42462588
  4. [4]Votto M, Olcese R, De Filippo M, Caminiti L, et al. Gastrointestinal manifestations during oral immunotherapy: A guide for pediatric allergists Pediatr Allergy Immunol, 2026.PMID 42430571
  5. [5]Arora S, Dellon ES Dupilumab Emerges as an Effective Antibody Therapy for Eosinophilic Esophagitis Annu Rev Med, 2026.PMID 42361381
  6. [6]Dash M, Ayub A, Vasudevan B, Sood A Correlation of disease activity (Urticaria Activity Score over 7 Days) and quality of life (Chronic Urticaria Quality of Life Questionnaire) in patients with chronic spontaneous urticaria: A prospective observational study Allergy Asthma Proc, 2026.PMID 42343500
  7. [7]Xi Y, Yao T, Zhang C, Zhuang T Effectiveness of safety care and clinical nursing pathway in patients undergoing cardiovascular intervention: a randomized controlled trial Perioper Med (Lond), 2026.PMID 42469924
  8. [8]Marks FJ, Walters SJ, Sutton L, Jacques RM What statistical methods are more appropriate for predicting recruitment at the design stage of a randomised controlled trial? Trials, 2026.PMID 42469922